These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Clinical significance of circulating microparticles for venous thromboembolism in cancer patients. Thaler J; Ay C; Pabinger I Hamostaseologie; 2012; 32(2):127-31. PubMed ID: 21792463 [TBL] [Abstract][Full Text] [Related]
12. Microparticles in health and disease. Enjeti AK; Lincz LF; Seldon M Semin Thromb Hemost; 2008 Oct; 34(7):683-91. PubMed ID: 19085769 [TBL] [Abstract][Full Text] [Related]
13. Microparticles, thrombosis and cancer. Aharon A; Brenner B Best Pract Res Clin Haematol; 2009 Mar; 22(1):61-9. PubMed ID: 19285273 [TBL] [Abstract][Full Text] [Related]
14. The role of microparticles in inflammation and thrombosis. Ardoin SP; Shanahan JC; Pisetsky DS Scand J Immunol; 2007; 66(2-3):159-65. PubMed ID: 17635793 [TBL] [Abstract][Full Text] [Related]
15. Pathophysiologic significance of procoagulant microvesicles in cancer disease and progression. Castellana D; Kunzelmann C; Freyssinet JM Hamostaseologie; 2009 Jan; 29(1):51-7. PubMed ID: 19151847 [TBL] [Abstract][Full Text] [Related]
16. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer. Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160 [TBL] [Abstract][Full Text] [Related]
20. Function and role of microparticles in various clinical settings. Nomura S; Ozaki Y; Ikeda Y Thromb Res; 2008; 123(1):8-23. PubMed ID: 18667228 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]